Catalyst Edge · Scanner · Tickers · GMED
CATALYST DOSSIER · UPDATED 2026-11-04

$GMED

biotech · convergence 7 · conviction WATCH
Convergence Score
7
Conviction
WATCH
Signals Firing
8
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $GMED?

GMED 7 WATCH biotech

Quantitative

  • Revenue (CY2026Q2): $789.6M (+5.9% YoY)
  • Net Income (CY2026Q2): $151.6M (-25.3% YoY)

Catalysts

  • Multi-spoke convergence: 8 convergent signals fired: earnings, finra_short, sc13d, congress, audit_extras

Risks

  • Position-sizing discipline: Conviction WATCH (7 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Squeeze unwind: Short interest can compress before retail catches the move — entry timing critical
  • Earnings binary: Print-day moves can swing ±15% — gap risk both directions

Sympathy basket (cerebro)

  • PCOR via tech r=+0.86 sympathetic (score 24)
  • BLZE via tech r=+0.86 sympathetic (score 23)
  • REED via staples r=-0.81 divergent (score 16)
  • CHSN via staples r=-0.81 divergent (score 13)
  • AMD via semis r=+0.77 sympathetic (score 22)
  • DIOD via semis r=+0.77 sympathetic (score 18)

Signals Firing

earningsfinra_shortsc13dcongressaudit_extrasauto_macro_adp_payrollsauto_macro_durable_goodsauto_macro_fx_rates
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for GMED. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Review the methodology and limitations and the dated audit. An intraday price touch is not trading profit.

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.
Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →

Optional product-learning preferences